ZIRITAXESTAT | ZIRITAXESTAT : LPC competitive inhibitor of ENPP2
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Control Compounds
Vendors

Probe Summary

More...

Targets Biochemical/Biophysical Potency Cellular Potency
ENPP2
  • Ki:15 nM
  • IC50:131 nM
  • IC50:242 nM
up to 1 uM

Selectivity

In Vitro Selectivity Assessment
Potency Assay Off-Target:
The compound was selective over related enzymes like ENPP1, phosphodiesterase 4 (PDE4) and PDE5 (enz ...

Potency
Cellular
In Vitro

ENPP2

Mode of Action: LPC competitive

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/acs.jmedchem.7b00032

In Vivo Validations

Mouse
Dose: 3 mg/Kg
Route of delivery: Oral
Plasma half life: 2.21 h
Cmax: 1075 ng/mL
Tmax: 3 h
Area Under the Curve:: 5553 ng*h/mL

DOI Reference: 10.1021/acs.jmedchem.7b00032

Dose: 10 mg/Kg
Route of delivery: Oral
Plasma half life: 2.22 h
Cmax: 4363 ng/mL
Tmax: 1 h
Area Under the Curve:: 20786 ng*h/mL

DOI Reference: 10.1021/acs.jmedchem.7b00032

Dose: 30 mg/Kg
Route of delivery: Oral
Plasma half life: 3.79 h
Cmax: 21367 ng/mL
Tmax: 1h
Area Under the Curve:: 101225 ng*h/mL

DOI Reference: 10.1021/acs.jmedchem.7b00032

Chemical Information

Molecular Formula C30H33FN8O2S
SMILEs CCc1nc2c(C)cc(N3CCN(CC(=O)N4CC(O)C4)CC3)cn2c1N(C)c1nc(-c2ccc(F)cc2)c(C#N)s1
InChI InChI=1S/C30H33FN8O2S/c1-4-24-29(35(3)30-34-27(25(14-32)42-30)20-5-7-21(31)8-6-20)39-15-22(13-19(2)28(39)33-24)37-11-9-36(10-12-37)18-26(41)38-16-23(40)17-38/h5-8,13,15,23,40H,4,9-12,16-18H2,1-3H3
Molecular weight 588.24 Da
AlogP 3.4324000000000012
HBond acceptors 10
HBond donors 1
Atoms 75

Expert Reviews


No SERP comments found for ZIRITAXESTAT

Probe ZIRITAXESTAT is in the process of SERP review.

Please continue to check back for new reviews and commentary.

If you would like to explore AI-generated evaluations, you may wish to visit the page for this compound on our collaborator website